EUCTR2015-003674-32-NL进行中（未招募）不适用
The effect of Telmisartan on inflammatory processes in the vascular wall of abdominal aortic aneurysms. - TELMI
eiden University Medical Center0 个研究点开始时间: 2015年10月26日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with an abdominal aortic aneurysm who are planned for elective open surgical repair.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 15
排除标准
- •1. Renal insufficiency; eGFR < 50 ml/min
- •2. Bloodpressure < 110/70 mmHg
- •3. Abnormal liver function (liver enzymes > 3 times elevated of normal value)
- •4. Hypersensitivity for angiotensin II type 1 receptor antagonist or ACE inhibitor
- •5. Current usage of angiotensin II type 1 receptor antagonist or ACE inhibitor
- •6. Known significant renal stenosis (>70%) of one or both renal arteries
- •7. Active gout
研究者
相似试验
尚未招募
2 期
The effect of Telmisartan on inflammatory processes in the vascular wall of abdominal aortic aneurysms.abdominal aortic aneurysm. aneurysm.10002363NL-OMON43688eids Universitair Medisch Centrum15
已完成
不适用
Anti-inflammatory effect of telmisartan in patients with hypertensioHypertensionJPRN-UMIN000009186Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine60
进行中（未招募）
不适用
Telmisartan und systemische Inflammationsparameter bei Patienten mit arterieller Hypertonie und asymtomatischer Koronarer Herzkrankheit - InflaTelEUCTR2006-002290-52-DEniversity Clinic Erlangen, Medical Clinic II
已完成
不适用
The effect of telmisartan on endothelial function in hypertensive patients.HypertensionJPRN-UMIN000005034Seigo Sugiyama20
已完成
2 期
Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)HIV-1 InfectionNCT01928927Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections58